Flightless I Homolog (FLII) (C-Term) Peptide
FLII
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN5673085
Quick Overview for Flightless I Homolog (FLII) (C-Term) Peptide (ABIN5673085)
Target
FLII
(Flightless I Homolog (FLII))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- C-Term
-
Sequence
- VINEGEEPEN FFWVGIGAQK PYDDDAEYMK HTRLFRCSNE KGYFAVTEKC
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti- FLII Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- FLII (Flightless I Homolog (FLII))
-
Background
-
This gene encodes a protein with a gelsolin-like actin binding domain and an N-terminal leucine-rich repeat-protein protein interaction domain. The protein is similar to a Drosophila protein involved in early embryogenesis and the structural organization of indirect flight muscle. The gene is located within the Smith-Magenis syndrome region on chromosome 17.
Alias Symbols: FLI, FLIL, Fli1
Protein Size: 1214 -
Gene ID
- 2314
-
NCBI Accession
- NM_001256264, NP_001243193
Target
-
You are here:
